Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis by Soler, Roberto et al.
503
Urinary Glycosaminoglycans and DMSO
International Braz J Urol Vol. 34 (4): 503-511, July - August, 2008
Urinary Glycosaminoglycans Excretion and the Effect of Dimethyl 
Sulfoxide in an Experimental Model of Non-Bacterial Cystitis
Roberto Soler, Homero Bruschini, Jose C. Truzzi, Joao R. Martins, Niels O. Camara, Maria T. 
Alves, Katia R. Leite, Helena B. Nader, Miguel Srougi, Valdemar Ortiz
Division of Urology (RS, JCT, VO), Division of Molecular Biology (JRM, HBN), Division of Nephrology 
(NOC) and Division of Pathology (MTA), Federal University of Sao Paulo, UNIFESP, and Division 


















Key words:  cystitis; dimethyl sulfoxide; glycosaminoglycans; rats; protamines
Int Braz J Urol.  2008; 34: 503-11
INTRODUCTION










LVDZHOOHVWDEOLVKHG WUHDWPHQW IRU ,&ZLWKSURYHQ
IHDVLELOLW\
Impaired barrier function of bladder epithe-
OLXPDQGVXEVHTXHQWLQ¿OWUDWLRQRIXULQHFRQWHQWVDUH
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H[SHFWHGLQLWLDOHYHQWVLQWKHSDWKRSK\VLRORJ\RI,&
*O\FRVDPLQRJO\FDQV*$*DUHFRPSOH[ORQJFKDLQ









DOVR JHQHUDOO\ HIIHFWLYH WUHDWPHQWV H[SHULPHQWDO
PRGHOV RI ,& DUH D FKDOOHQJLQJ ILHOG 3URWDPLQH
VXOIDWH 36KDVEHHQXVHG LQH[SHULPHQWDOPRGHOV
RI ,&ZKLFK DW D ORZ FRQFHQWUDWLRQ PJP/
UHSUHVHQWVDQRQF\WRWR[LFDIIURQWWRXURWKHOLDOEDUULHU
LQVWHDGRIDEODGGHULUULWDQW36LVDSRO\FDWLRQLF
































ORZLQJWKHSURFHGXUHst to 7thWKDQGWK GD\V
WRWDOQ 7KHUDWVZHUHKRXVHGKRXUVSULRU
WR VDFUL¿FH LQ DPHWDEROLF FDJH LQ RUGHU WR FROOHFW
XULQH7KHEODGGHUZDVUHPRYHGDQG¿[HGLQQRUPDO
EXIIHUHG IRUPDOLQ DQGXULQHZDV LPPHGLDWHO\

























PRQRQXFOHDU /01 LQ  FURVV VHFWLRQV DW;
PDJQL¿FDWLRQDWWKHPRVWLQ¿OWUDWHGDUHD
Measurement of Urinary Hyaluronic Acid
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SURWHLQV +$%3 DQG VXFFHVVLYHO\ LQFXEDWHGZLWK
VDPSOHV FRQWDLQLQJ VWDQGDUG VROXWLRQV RI+$ RU
XULQH VDPSOHV IURP WKH GLIIHUHQW JURXSV ELRWLQ
FRQMXJDWHG+$%3 DQG HXURSLXPODEHOHG VWUHSWD-
YLGLQ$PHUVKDP/LIH6FLHQFH%XFNLQJKDPVKLUH






























LQJ6WXGHQW¶VWWHVW IRU SDUDPHWULF GDWD DQG0DQQ
:KLWQH\8WHVWIRUQRQSDUDPHWULFGDWD&RPSDULVRQ
EHWZHHQDOOWKHJURXSVZDVFDUULHGRXWE\$129$
ZKHQ QRUPDO GLVWULEXWLRQ RU.UXVNDO:DOOLV WHVW
ZLWKRXWQRUPDOGLVWULEXWLRQIROORZHGE\'XQQ¶VRU
7XNH\PXOWLSOHFRPSDULVRQWHVWV:HXVHGWKH6LJPD
































LQFUHDVHGRQO\RQ WKHthGD\  LQ WKH'062JURXS
7DEOH
GAG Measurement




GD\V&RPSDUHGZLWK WKH OHYHOV GHWHFWHG DW GD\ 
DQLPDOV+$&URQWKHstGD\ZDVLQFUHDVHGIROG
and on the 7thGD\IROGS)LJXUH$
 8ULQDU\ 6*$*&U IROORZHG DQ DOPRVW
VLPLODUSDWWHUQRIH[FUHWLRQIROORZLQJ36LQMHFWLRQ
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LQFUHDVLQJ DW WKH¿UVW GD\ZLWK DPRUH UHPDUNDEOH
SHDNDWWKHthGD\8ULQDU\6*$*&UOHYHOVDWth







'062KDG VLJQL¿FDQWO\ UHGXFHG OHYHO RI XULQDU\






DZHOO GRFXPHQWHG HIIHFW RI LQFUHDVLQJ XURWKHOLDO
SHUPHDELOLW\36LQFUHDVHGZDWHUDQGXUHDSHUPHDELO-
LW\UHGXFHGWKHWUDQVHSLWKHOLDOUHVLVWDQFHSURYRNHG
SDWFK\XPEUHOOD FHOO O\VLV DQGGDPDJH WR WKH WLJKW
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Table 1 – Pathological features in DMSO groups.
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of action and effects on bladder tissue function are 
QRWFRPSOHWHO\XQGHUVWRRG
 $VZH IRXQG WZRPDMRU SHDNV RI LQÀDP-
PDWLRQZHH[DPLQHGWKHHIIHFWRI'062RQWKHVH
LQIODPPDWRU\ FKDQJHV DQG DOVR RQ KHDOWK\ EODG-
GHUV'062VLJQL¿FDQWO\UHGXFHGWKHLQÀDPPDWRU\
SURFHVV DW ERWKst and 7th GD\V DIWHU WKHXURWKHOLDO
LQMXU\ZKLFK SURYHV LWV DQWLLQÀDPPDWRU\ DFWLRQ
LQWKHEODGGHU&RQYHUVHO\WKLVGUXJSURYRNHGPLOG
LQÀDPPDWLRQLQQRUPDOPXFRVD7KLV¿QGLQJPLJKW
support the initial complaint from some patients of 

































,& 5HFHQWO\ LQFUHDVHG XULQDU\6*$*  DQG
+$OHYHOVZHUHDVVRFLDWHGZLWKVHYHUH,&EDVHGRQ
DV\PSWRPTXHVWLRQQDLUH



















 +$DOVR KDV DQ LQÀXHQFHRQ LQÀDPPDWLRQ
SURFHVV VXFK DVPLJUDWLRQ GLIIHUHQWLDWLRQ FHOOXODU
SUROLIHUDWLRQ DQJLRJHQHVLV DQG LQGXFWLRQRI SURLQ-
ÀDPPDWRU\ F\WRNLQHV DQG FKHPRNLQHV'XULQJ LQ-
ÀDPPDWLRQRUDIWHULQMXU\+$PD\HLWKHUEHGHJUDGHG




Table 2 – Urinary GAG levels in DMSO groups.
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FRQFRPLWDQWZLWK 301 DQG/01 LQILOWUDWH7KH
WUHDWPHQWZLWK'062UHGXFHG WKHVH LQÀDPPDWRU\
FKDQJHV7KLVORFDODQWLLQÀDPPDWRU\DFWLRQPD\EH
DPHFKDQLVPE\ZKLFK LW H[HUWVDEHQH¿FLDO HIIHFW
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